Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 13:75:9.21.1-9.21.35.
doi: 10.1002/cpph.14.

Functional Studies of Sodium Channels: From Target to Compound Identification

Daniel Bertrand  1 , Bruno Biton  2 , Thomas Licher  3 , Jean-Marie Chambard  2 , Christophe Lanneau  2 , Michel Partiseti  2 , Isabel A Lefevre  2
Affiliations
Review

Functional Studies of Sodium Channels: From Target to Compound Identification

Daniel Bertrand et al. Curr Protoc Pharmacol. .

Abstract

Over the last six decades, voltage-gated sodium (Nav ) channels have attracted a great deal of scientific and pharmaceutical interest, driving fundamental advances in both biology and technology. The structure and physiological function of these channels have been extensively studied; clinical and genetic data have uncovered their implication in diseases such as epilepsy, arrhythmias, and pain, bringing them into focus as current and future drug targets. While different techniques have been established to record the activity of Nav channels, proper determination of their properties still presents serious challenges, depending upon the experimental conditions and the desired subtype of channel to be characterized. The aim of this unit is to review the characteristics of Nav channels, their properties, the cells in which they can be studied, and the currently available techniques. Topics covered include the determination of Nav -channel biophysical properties as well as the use of toxins to discriminate between subtypes using electrophysiological or optical methods. Perspectives on the development of high-throughput screening assays with their advantages and limitations are also discussed to allow a better understanding of the challenges encountered in voltage-gated sodium channel preclinical drug discovery. © 2016 by John Wiley & Sons, Inc.

Keywords: electrophysiology; fluorescent readout; high throughput; screening; voltage-gated sodium channels.

PubMed Disclaimer

References

Literature Cited

    1. Ahuja, S. , Mukund, S. , Deng, L. , Khakh, K. , Chang, E. , Ho, H. , Shriver, S. , Young, C. , Lin, S. , Johnson, J.P. Jr. , Wu, P. , Li, J. , Coons, M. , Tam, C. , Brillantes, B. , Sampang, H. , Mortara, K. , Bowman, K.K. , Clark, K.R. , Estevez, A. , Xie, Z. , Verschoof, H. , Grimwood, M. , Dehnhardt, C. , Andrez, J.C. , Focken, T. , Sutherlin, D.P. , Safina, B.S. , Starovasnik, M.A. , Ortwine, D.F. , Franke, Y. , Cohen, C.J. , Hackos, D.H. , Koth, C.M. , and Payandeh, J. 2015. Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. Science 350:aac5464. doi: 10.1126/science.aac5464.
    1. Armstrong, C.M. 2006. Na channel inactivation from open and closed states. Proc. Natl. Acad Sci. U.S.A. 103:17991-17996. doi: 10.1073/pnas.0607603103.
    1. Barnes, S. and Hille, B. 1988. Veratridine modifies open sodium channels. J. Gen. Physiol. 91:421-443. doi: 10.1085/jgp.91.3.421.
    1. Belardetti, F. , Tringham, E. , Eduljee, C. , Jiang, X. , Dong, H. , Hendricson, A. , Shimizu, Y. , Janke, D.L. , Parker, D. , Mezeyova, J. , Khawaja, A. , Pajouhesh, H. , Fraser, R.A. , Arneric, S.P. , and Snutch, T.P. 2009. A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockers. Assay Drug Dev. Technol. 7:266-280. doi: 10.1089/adt.2009.191.
    1. Belardinelli, L. , Liu, G. , Smith-Maxwell, C. , Wang, W.Q. , El-Bizri, N. , Hirakawa, R. , Karpinski, S. , Li, C.H. , Hu, L. , Li, X.J. , Crumb, W. , Wu, L. , Koltun, D. , Zablocki, J. , Yao, L. , Dhalla, A.K. , Rajamani, S. , and Shryock, J.C. 2013. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. J. Pharmacol. Exp. Ther. 344:23-32. doi: 10.1124/jpet.112.198887.

LinkOut - more resources